A novel and selective c-Met inhibitor against subcutaneous xenograft and othotopic brain tumor models

被引：2

作者：

Cui, Yumin ^{[1
]}

Dai, Guangxiu ^{[1
]}

Ren, Yongxin ^{[1
]}

Zhou, Feng ^{[1
]}

Fan, Shiming ^{[1
]}

Sai, Yang ^{[1
]}

Gu, Yi ^{[1
]}

Yan, James ^{[1
]}

Li, Jia ^{[1
]}

Qing, Weiguo ^{[1
]}

Su, Weiguo ^{[1
]}

机构：

[1] Hutchison MediPharma Ltd, Shanghai, Peoples R China

来源：

CANCER RESEARCH | 2011年 / 71卷

关键词：

D O I：

10.1158/1538-7445.AM2011-3612

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3612

引用

页数：1

共 50 条

[1] Volitinib, a potent and highly selective c-Met inhibitor, effectively blocks c-Met signaling and growth in c-MET amplified gastric cancer patient-derived tumor xenograft models
Gavine, Paul R.
Ren, Yongxin
Han, Lu
Lu, Jing
Fan, Shiming
Zhang, Wei
Xu, Wen
Liu, Yuan Jie
Zhang, Tianwei
Fu, Haihua
Yu, Yongjuan
Wang, Huiying
Xu, Shirlian
Zhou, Feng
Su, Xinying
Yin, XiaoLu
Xie, Liang
Wang, Linfang
Qing, Weiguo
Jiao, Longxian
Su, Weiguo
Wang, Q. May
[J]. MOLECULAR ONCOLOGY, 2015, 9 (01) : 323 - 333
[2] Sensitivity of Selected Human Tumor Models to PF-04217903, a Novel Selective c-Met Kinase Inhibitor
Zou, Helen Y.
Li, Qiuhua
Lee, Joseph H.
Arango, Maria E.
Burgess, Kristina
Qiu, Ming
Engstrom, Lars D.
Yamazaki, Shinji
Parker, Max
Timofeevski, Sergei
Cui, Jingrong Jean
McTigue, Michele
Los, Gerrit
Bender, Steven L.
Smeal, Tod
Christensen, James G.
[J]. MOLECULAR CANCER THERAPEUTICS, 2012, 11 (04) : 1036 - 1047
[3] Discovery of a selective c-MET inhibitor with a novel binding mode
Collie, Gavin W.
Barlind, Louise
Bazzaz, Sana
Borjesson, Ulf
Dale, Ian L.
Disch, Jeremy S.
Habeshian, Sevan
Jetson, Rachael
Khurana, Puneet
Madin, Andrew
Michaelides, Iacovos N.
Peng, Ling
Snijder, Arjan
Stubbs, Christopher J.
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 75
[4] Cabozantinib, a Novel c-Met Inhibitor, Inhibits Colorectal Cancer Development in a Xenograft Model
Sun, Yinggang
Sun, Liyong
An, Yanxin
Shen, Xin
[J]. MEDICAL SCIENCE MONITOR, 2015, 21 : 2316 - 2321
[5] Autocrine c-met/HGF HCC patient derived xenograft (PDX) models for evaluating c-met inhibitors
Chen, Dawei
Song, Xiaoming
Call, Jie
Chen, Taiping
Chen, Yiyou
Li, Henry Q. X.
[J]. CANCER RESEARCH, 2012, 72
[6] The selective c-Met inhibitor tepotinib can overcome epidermal growth factor receptor inhibitor resistance mediated by aberrant c-Met activation in NSCLC models
Friese-Hamim, Manja
Bladt, Friedhelm
Locatelli, Giuseppe
Stammberger, Uz
Blaukat, Andree
[J]. AMERICAN JOURNAL OF CANCER RESEARCH, 2017, 7 (04): : 962 - 972
[7] Preclinical Evaluation of SCC244 (Glumetinib), a Novel, Potent, and Highly Selective Inhibitor of c-Met in MET-dependent Cancer Models
Ai, Jing
Chen, Yi
Peng, Xia
Ji, Yinchun
Xi, Yong
Shen, Yanyan
Yang, Xinying
Su, Yi
Sun, Yiming
Gao, Yinglei
Ma, Yuchi
Xiong, Bing
Shen, Jingkang
Ding, Jian
Geng, Meiyu
[J]. MOLECULAR CANCER THERAPEUTICS, 2018, 17 (04) : 751 - 762
[8] Discovery of a highly selective and potent small molecule inhibitor against c-MET for cancer therapy
Bao, Rudi
Pan, Zhongzong
Zhao, Zhiming
Yu, Hongping
Xu, Yaochang
[J]. CANCER RESEARCH, 2015, 75
[9] Preclinical Evaluation of a Novel c-Met Inhibitor in a Gastric Cancer Xenograft Model Using Small Animal PET
Wiehr, Stefan
von Ahsen, Oliver
Roese, Lars
Mueller, Andre
Mannheim, Julia G.
Honndorf, Valerie
Kukuk, Damaris
Reischl, Gerald
Pichler, Bernd J.
[J]. MOLECULAR IMAGING AND BIOLOGY, 2013, 15 (02) : 203 - 211
[10] Preclinical Evaluation of a Novel c-Met Inhibitor in a Gastric Cancer Xenograft Model Using Small Animal PET
Stefan Wiehr
Oliver von Ahsen
Lars Röse
Andre Mueller
Julia G. Mannheim
Valerie Honndorf
Damaris Kukuk
Gerald Reischl
Bernd J. Pichler
[J]. Molecular Imaging and Biology, 2013, 15 : 203 - 211

← 1 2 3 4 5 →